Small cell lung cancer: Clinical practice guidelines in oncology

Gregory P. Kalemkerian; Wallace Akerley; Paul Bogner; Hossein Borghaei; Laura QM Chow; Robert J. Downey; Leena Gandhi; Apar Kishor P. Ganti; Ramaswamy Govindan; John C. Grecula; James Hayman; Rebecca Suk Heist; Leora Horn; Thierry Jahan; Marianna Koczywas; Billy W. Loo; Robert E. Merritt; Cesar A. Moran; Harvey B. Niell; Janis O'Malley; Jyoti D. Patel; Neal Ready; Charles M. Rudin; Charles C. Williams; Kristina Gregory; Miranda Hughes

doi:10.6004/jnccn.2013.0011

Small cell lung cancer: Clinical practice guidelines in oncology

Gregory P. Kalemkerian
, Wallace Akerley
, Paul Bogner
, Hossein Borghaei
, Laura QM Chow
, Robert J. Downey
, Leena Gandhi
, Apar Kishor P. Ganti
, Ramaswamy Govindan
, John C. Grecula
, James Hayman
, Rebecca Suk Heist
, Leora Horn
, Thierry Jahan
, Marianna Koczywas
, Billy W. Loo
, Robert E. Merritt
, Cesar A. Moran
, Harvey B. Niell
, Janis O'Malley

Jyoti D. Patel, Neal Ready, Charles M. Rudin, Charles C. Williams, Kristina Gregory, Miranda Hughes

University of Michigan, Ann Arbor
University of Utah
Roswell Park Cancer Institute
Fred Hutchinson Cancer Research Center
Memorial Sloan-Kettering Cancer Center
Dana-Farber/Brigham and Women's Cancer Center
Nebraska Medicine
Washington University St. Louis
Ohio State University
Massachusetts General Hospital Cancer Center
Vanderbilt University
University of California at San Francisco
City of Hope National Medical Center
Stanford University
University of Texas MD Anderson Cancer Center
St. Jude Children Research Hospital
University of Alabama at Birmingham
Northwestern University
Duke University
Johns Hopkins University
University of South Florida

Research output: Contribution to journal › Article › peer-review

366 Scopus citations

Abstract

Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.

Original language	English
Pages (from-to)	78-98
Number of pages	21
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	11
Issue number	1
DOIs	https://doi.org/10.6004/jnccn.2013.0011
State	Published - Jan 1 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antineoplastic Agents/therapeutic use
Brain Neoplasms/prevention & control
Humans
Lung Neoplasms/pathology
Neoplasm Staging
Radiotherapy
Small Cell Lung Carcinoma/secondary

Access to Document

10.6004/jnccn.2013.0011

Cite this

Kalemkerian, G. P., Akerley, W., Bogner, P., Borghaei, H., Chow, L. QM., Downey, R. J., Gandhi, L., Ganti, A. K. P., Govindan, R., Grecula, J. C., Hayman, J., Heist, R. S., Horn, L., Jahan, T., Koczywas, M., Loo, B. W., Merritt, R. E., Moran, C. A., Niell, H. B., ... Hughes, M. (2013). Small cell lung cancer: Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN, 11(1), 78-98. https://doi.org/10.6004/jnccn.2013.0011

@article{34970f8ab5f84f37ad780496fa913ffa,

title = "Small cell lung cancer: Clinical practice guidelines in oncology",

abstract = "Neuroendocrine tumors account for approximately 20\% of lung cancers; most (≈15\%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.",

keywords = "Antineoplastic Agents/therapeutic use, Brain Neoplasms/prevention \& control, Humans, Lung Neoplasms/pathology, Neoplasm Staging, Radiotherapy, Small Cell Lung Carcinoma/secondary",

author = "Kalemkerian, \{Gregory P.\} and Wallace Akerley and Paul Bogner and Hossein Borghaei and Chow, \{Laura QM\} and Downey, \{Robert J.\} and Leena Gandhi and Ganti, \{Apar Kishor P.\} and Ramaswamy Govindan and Grecula, \{John C.\} and James Hayman and Heist, \{Rebecca Suk\} and Leora Horn and Thierry Jahan and Marianna Koczywas and Loo, \{Billy W.\} and Merritt, \{Robert E.\} and Moran, \{Cesar A.\} and Niell, \{Harvey B.\} and Janis O'Malley and Patel, \{Jyoti D.\} and Neal Ready and Rudin, \{Charles M.\} and Williams, \{Charles C.\} and Kristina Gregory and Miranda Hughes",

year = "2013",

month = jan,

day = "1",

doi = "10.6004/jnccn.2013.0011",

language = "English",

volume = "11",

pages = "78--98",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Harborside Press",

number = "1",

}

Kalemkerian, GP, Akerley, W, Bogner, P, Borghaei, H, Chow, LQM, Downey, RJ, Gandhi, L, Ganti, AKP, Govindan, R, Grecula, JC, Hayman, J, Heist, RS, Horn, L, Jahan, T, Koczywas, M, Loo, BW, Merritt, RE, Moran, CA, Niell, HB, O'Malley, J, Patel, JD, Ready, N, Rudin, CM, Williams, CC, Gregory, K & Hughes, M 2013, 'Small cell lung cancer: Clinical practice guidelines in oncology', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 11, no. 1, pp. 78-98. https://doi.org/10.6004/jnccn.2013.0011

TY - JOUR

T1 - Small cell lung cancer

T2 - Clinical practice guidelines in oncology

AU - Kalemkerian, Gregory P.

AU - Akerley, Wallace

AU - Bogner, Paul

AU - Borghaei, Hossein

AU - Chow, Laura QM

AU - Downey, Robert J.

AU - Gandhi, Leena

AU - Ganti, Apar Kishor P.

AU - Govindan, Ramaswamy

AU - Grecula, John C.

AU - Hayman, James

AU - Heist, Rebecca Suk

AU - Horn, Leora

AU - Jahan, Thierry

AU - Koczywas, Marianna

AU - Loo, Billy W.

AU - Merritt, Robert E.

AU - Moran, Cesar A.

AU - Niell, Harvey B.

AU - O'Malley, Janis

AU - Patel, Jyoti D.

AU - Ready, Neal

AU - Rudin, Charles M.

AU - Williams, Charles C.

AU - Gregory, Kristina

AU - Hughes, Miranda

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.

AB - Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈15%) are small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for SCLC focus on extensive-stage SCLC because it occurs more frequently than limited-stage disease. SCLC is highly sensitive to initial therapy; however, most patients eventually die of recurrent disease. In patients with extensive-stage disease, chemotherapy alone can palliate symptoms and prolong survival in most patients; however, long-term survival is rare. Most cases of SCLC are attributable to cigarette smoking; therefore, smoking cessation should be strongly promoted.

KW - Antineoplastic Agents/therapeutic use

KW - Brain Neoplasms/prevention & control

KW - Humans

KW - Lung Neoplasms/pathology

KW - Neoplasm Staging

KW - Radiotherapy

KW - Small Cell Lung Carcinoma/secondary

UR - https://www.scopus.com/pages/publications/84874589027

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000313575200011&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.6004/jnccn.2013.0011

DO - 10.6004/jnccn.2013.0011

M3 - Article

C2 - 23307984

SN - 1540-1405

VL - 11

SP - 78

EP - 98

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 1

ER -

Small cell lung cancer: Clinical practice guidelines in oncology

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this